Drug Type Triple payload Antibody drug conjugate (Triple payload ADC) |
Synonyms- |
Action inhibitors |
Mechanism TOP1 inhibitors(DNA topoisomerase I inhibitors), Tubulin inhibitors, nectin-4 inhibitors(Nectin-4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC39H67N5O7 |
InChIKeyDASWEROEPLKSEI-UIJRFTGLSA-N |
CAS Registry474645-27-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Triple Negative Breast Cancer | Preclinical | Switzerland | 30 Apr 2025 |